GlassScriptPhysician profile
Claire Bruce
NPI 1245866417
$12,384.07
in general payments reported to CMS, 2019-2025
71 companies · $2,399 in 2025
The $2,399 reported for 2025 was more than what 95% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,566 · 2022: $3,718 · 2023: $1,833 · 2024: $2,869 · 2025: $2,399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,375 · Consulting Fee: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,374.98 |
| Consulting Fee | $725.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,354.87 | 2021-2025 | Calquence, Imfinzi, Lynparza |
| Inspire Medical Systems, INC. | $1,245.58 | 2022 | |
| Glaxosmithkline, LLC. | $855.48 | 2021-2025 | Ojjaara, Jemperli, Zejula |
| Novartis Pharmaceuticals Corporation | $838.58 | 2022-2025 | |
| Janssen Biotech, INC. | $729.73 | 2022-2025 | Rybrevant, Darzalex, Tecvayli |
| Boehringer Ingelheim Pharmaceuticals, INC. | $561.53 | 2021-2025 | Gilotrif |
| Pfizer INC. | $452.20 | 2022-2025 | |
| Beigene USA, INC. | $430.67 | 2024-2025 | Brukinsa, Tevimbra |
| Seagen INC. | $346.29 | 2022-2023 | Padcev, Tukysa, Adcetris |
| Regeneron Healthcare Solutions, INC. | $304.86 | 2021-2025 | Libtayo |
| Celgene Corporation | $302.42 | 2023-2025 | Reblozyl |
| Daiichi Sankyo INC. | $290.47 | 2022-2025 | Enhertu, Datroway |
| E.R. Squibb & Sons, L.L.C. | $282.82 | 2022-2025 | Opdivo, Opdualag |
| Merck Sharp & Dohme LLC | $260.41 | 2022-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Grifols USA, LLC | $244.87 | 2021-2022 |
Show all 71 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $208.10 | 2021-2022 | |
| Beone Medicines USA, INC. | $180.78 | 2025 | Brukinsa, Tevimbra |
| Mylan Specialty L.P. | $173.95 | 2021-2022 | |
| Gilead Sciences, INC. | $159.93 | 2021-2025 | Trodelvy |
| Janssen Scientific Affairs, LLC | $155.50 | 2024-2025 | Rybrevant, Erleada, Darzalex |
| Amgen INC. | $146.64 | 2021-2025 | Tezspire, Kyprolis, Blincyto |
| Alexion Pharmaceuticals, INC. | $127.11 | 2023-2025 | Ultomiris, Soliris |
| Stemline Therapeutics INC. | $120.96 | 2023-2025 | Orserdu |
| Genzyme Corporation | $120.03 | 2022-2025 | |
| Ipsen Biopharmaceuticals, INC | $113.94 | 2023-2024 | Somatuline Depot, Onivyde |
| Incyte Corporation | $112.49 | 2023-2025 | Jakafi, Monjuvi, Pemazyre |
| Takeda Pharmaceuticals U.S.A., INC. | $112.33 | 2021-2025 | Fruzaqla |
| Karyopharm Therapeutics INC. | $110.10 | 2022-2023 | Xpovio |
| Jazz Pharmaceuticals INC. | $106.32 | 2021-2025 | |
| Abbvie INC. | $106.18 | 2023-2025 | |
| Lilly USA, LLC | $97.05 | 2022-2025 | Verzenio, Jaypirca, Retevmo |
| Eisai INC. | $90.35 | 2022-2025 | |
| Blueprint Medicines Corporation | $87.02 | 2022-2025 | Ayvakit |
| Springworks Therapeutics, INC. | $86.03 | 2024-2025 | Ogsiveo |
| Array Biopharma INC | $85.23 | 2023-2025 | Mektovi, Braftovi, Lorbrena |
| Genentech USA, INC. | $75.68 | 2021-2023 | Hemlibra |
| Harmony Biosciences LLC | $75.39 | 2021-2022 | |
| Sobi, INC | $74.23 | 2022-2024 | |
| La Jolla Pharmaceutical Company | $73.98 | 2021-2022 | |
| Puma Biotechnology, INC. | $68.53 | 2022-2023 | |
| Adaptive Biotechnologies Corporation | $65.52 | 2023-2024 | Clonoseq |
| Pharmacyclics LLC, An Abbvie Company | $65.11 | 2022-2023 | Epkinly, Imbruvica |
| Adc Therapeutics America, INC. | $63.71 | 2023-2024 | |
| Pharmaessentia USA Corporation | $62.03 | 2023-2024 | Besremi |
| United Therapeutics Corporation | $61.56 | 2021-2022 | |
| Astellas Pharma US INC | $49.87 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.79 | 2023 | |
| Sumitomo Pharma America, INC. | $39.12 | 2024-2025 | Orgovyx |
| Tersera Therapeutics LLC | $38.31 | 2022-2023 | Xermelo |
| Exelixis INC. | $36.40 | 2022-2025 | Cabometyx |
| Emd Serono, INC. | $35.93 | 2022-2024 | |
| Genmab U.S., INC. | $35.88 | 2023-2025 | Epkinly |
| Agios Pharmaceuticals, INC. | $35.03 | 2024 | Pyrukynd |
| Acrotech Biopharma INC. | $34.56 | 2025 | Beleodaq |
| Aveo Pharmaceuticals, INC. | $33.97 | 2023-2025 | Fotivda |
| Mirati Therapeutics, INC. | $31.02 | 2023 | Krazati |
| Servier Pharmaceuticals LLC | $28.42 | 2024-2025 | |
| Iovance Biotherapeutics, INC. | $26.78 | 2025 | Amtagvi |
| Coherus Oncology, INC. | $21.44 | 2022 | |
| Cti Biopharma Corp. | $19.99 | 2023 | Vonjo |
| Rigel Pharmaceuticals, INC. | $19.81 | 2023 | Rezlidhia, Tavalisse |
| Tolmar, INC. | $19.52 | 2023 | |
| Philips North America LLC | $19.21 | 2023 | |
| Recordati_rare_diseases_inc. | $18.26 | 2025 | Enjaymo |
| Myriad Genetic Laboratories, INC. | $17.85 | 2022 | |
| Myovant Sciences INC. | $17.68 | 2022 | |
| Deciphera Pharmaceuticals INC. | $17.58 | 2024 | Qinlock |
| Kite Pharma, INC. | $17.03 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $15.45 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $12.09 | 2021 | |
| Inogen, INC. | $9.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claire Bruce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.